nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—GNRHR—hindbrain—Parkinson's disease	0.0282	0.0849	CbGeAlD
Danazol—GNRHR—brainstem—Parkinson's disease	0.0162	0.0487	CbGeAlD
Danazol—CCL2—embryo—Parkinson's disease	0.0138	0.0415	CbGeAlD
Danazol—SHBG—hindbrain—Parkinson's disease	0.0129	0.0387	CbGeAlD
Danazol—CCL2—forebrain—Parkinson's disease	0.0122	0.0367	CbGeAlD
Danazol—PGR—hindbrain—Parkinson's disease	0.0116	0.0348	CbGeAlD
Danazol—CCL2—cardiovascular system—Parkinson's disease	0.0103	0.031	CbGeAlD
Danazol—ESR1—hindbrain—Parkinson's disease	0.00906	0.0273	CbGeAlD
Danazol—GNRHR—head—Parkinson's disease	0.00894	0.0269	CbGeAlD
Danazol—CCL2—medulla oblongata—Parkinson's disease	0.00881	0.0265	CbGeAlD
Danazol—GNRHR—nervous system—Parkinson's disease	0.00848	0.0255	CbGeAlD
Danazol—GNRHR—central nervous system—Parkinson's disease	0.00816	0.0246	CbGeAlD
Danazol—CCL2—midbrain—Parkinson's disease	0.00805	0.0242	CbGeAlD
Danazol—GNRHR—cerebellum—Parkinson's disease	0.00798	0.024	CbGeAlD
Danazol—CCL2—spinal cord—Parkinson's disease	0.00785	0.0236	CbGeAlD
Danazol—SHBG—brainstem—Parkinson's disease	0.00737	0.0222	CbGeAlD
Danazol—CCL2—head—Parkinson's disease	0.00698	0.021	CbGeAlD
Danazol—CCL2—nervous system—Parkinson's disease	0.00662	0.0199	CbGeAlD
Danazol—GNRHR—brain—Parkinson's disease	0.00648	0.0195	CbGeAlD
Danazol—CCL2—central nervous system—Parkinson's disease	0.00637	0.0192	CbGeAlD
Danazol—CCL2—cerebellum—Parkinson's disease	0.00623	0.0187	CbGeAlD
Danazol—SHBG—cardiovascular system—Parkinson's disease	0.00601	0.0181	CbGeAlD
Danazol—CYP19A1—forebrain—Parkinson's disease	0.00577	0.0173	CbGeAlD
Danazol—ESR1—embryo—Parkinson's disease	0.00567	0.017	CbGeAlD
Danazol—PGR—cardiovascular system—Parkinson's disease	0.00542	0.0163	CbGeAlD
Danazol—ESR1—brainstem—Parkinson's disease	0.00519	0.0156	CbGeAlD
Danazol—AR—forebrain—Parkinson's disease	0.0051	0.0154	CbGeAlD
Danazol—CCL2—brain—Parkinson's disease	0.00506	0.0152	CbGeAlD
Danazol—ESR1—forebrain—Parkinson's disease	0.00501	0.0151	CbGeAlD
Danazol—AR—cardiovascular system—Parkinson's disease	0.00432	0.013	CbGeAlD
Danazol—Testosterone Propionate—COMT—Parkinson's disease	0.00431	0.412	CrCbGaD
Danazol—ESR1—cardiovascular system—Parkinson's disease	0.00424	0.0127	CbGeAlD
Danazol—SHBG—central nervous system—Parkinson's disease	0.00372	0.0112	CbGeAlD
Danazol—PGR—head—Parkinson's disease	0.00367	0.011	CbGeAlD
Danazol—SHBG—cerebellum—Parkinson's disease	0.00363	0.0109	CbGeAlD
Danazol—PGR—nervous system—Parkinson's disease	0.00348	0.0105	CbGeAlD
Danazol—PGR—central nervous system—Parkinson's disease	0.00335	0.0101	CbGeAlD
Danazol—CYP19A1—head—Parkinson's disease	0.0033	0.00993	CbGeAlD
Danazol—AR—spinal cord—Parkinson's disease	0.00329	0.00989	CbGeAlD
Danazol—PGR—cerebellum—Parkinson's disease	0.00327	0.00985	CbGeAlD
Danazol—CYP19A1—nervous system—Parkinson's disease	0.00313	0.00942	CbGeAlD
Danazol—CYP19A1—central nervous system—Parkinson's disease	0.00301	0.00907	CbGeAlD
Danazol—SHBG—brain—Parkinson's disease	0.00295	0.00888	CbGeAlD
Danazol—AR—head—Parkinson's disease	0.00292	0.00879	CbGeAlD
Danazol—ESR1—head—Parkinson's disease	0.00287	0.00863	CbGeAlD
Danazol—AR—nervous system—Parkinson's disease	0.00277	0.00834	CbGeAlD
Danazol—ESR1—nervous system—Parkinson's disease	0.00272	0.00818	CbGeAlD
Danazol—AR—central nervous system—Parkinson's disease	0.00267	0.00803	CbGeAlD
Danazol—PGR—brain—Parkinson's disease	0.00266	0.008	CbGeAlD
Danazol—ESR1—central nervous system—Parkinson's disease	0.00262	0.00788	CbGeAlD
Danazol—ESR1—cerebellum—Parkinson's disease	0.00256	0.0077	CbGeAlD
Danazol—CYP19A1—brain—Parkinson's disease	0.00239	0.0072	CbGeAlD
Danazol—AR—brain—Parkinson's disease	0.00212	0.00637	CbGeAlD
Danazol—ESR1—brain—Parkinson's disease	0.00208	0.00626	CbGeAlD
Danazol—CYP3A4—nervous system—Parkinson's disease	0.00152	0.00457	CbGeAlD
Danazol—CYP3A4—central nervous system—Parkinson's disease	0.00146	0.0044	CbGeAlD
Danazol—Testosterone—MAOA—Parkinson's disease	0.00141	0.135	CrCbGaD
Danazol—Ethinyl Estradiol—ABCB1—Parkinson's disease	0.000861	0.0824	CrCbGaD
Danazol—Prednisone—ABCB1—Parkinson's disease	0.00084	0.0804	CrCbGaD
Danazol—Norethindrone—ABCB1—Parkinson's disease	0.000828	0.0792	CrCbGaD
Danazol—Progesterone—CYP2D6—Parkinson's disease	0.000676	0.0646	CrCbGaD
Danazol—Hydrocortisone—ABCB1—Parkinson's disease	0.000592	0.0567	CrCbGaD
Danazol—CCL2—Signaling by GPCR—DRD2—Parkinson's disease	0.000484	0.000736	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HTR7—Parkinson's disease	0.000484	0.000736	CbGpPWpGaD
Danazol—Progesterone—ABCB1—Parkinson's disease	0.000483	0.0462	CrCbGaD
Danazol—PGR—Signaling Pathways—DGKQ—Parkinson's disease	0.000482	0.000733	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GPR37—Parkinson's disease	0.000482	0.000733	CbGpPWpGaD
Danazol—AR—Gene Expression—TAF1—Parkinson's disease	0.00048	0.00073	CbGpPWpGaD
Danazol—AR—Gene Expression—NR4A2—Parkinson's disease	0.00048	0.00073	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000474	0.000721	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GFAP—Parkinson's disease	0.000463	0.000704	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GRM5—Parkinson's disease	0.000458	0.000696	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000457	0.000696	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000457	0.000695	CbGpPWpGaD
Danazol—Testosterone—ABCB1—Parkinson's disease	0.000456	0.0436	CrCbGaD
Danazol—GNRHR—Signaling Pathways—PDYN—Parkinson's disease	0.00045	0.000685	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00045	0.000685	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—CTGF—Parkinson's disease	0.000449	0.000684	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—DRD2—Parkinson's disease	0.000442	0.000673	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HTR7—Parkinson's disease	0.000442	0.000673	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000441	0.000671	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000433	0.000659	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ND3—Parkinson's disease	0.000424	0.000645	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MCCC1—Parkinson's disease	0.000424	0.000645	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GFAP—Parkinson's disease	0.000423	0.000644	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GRM5—Parkinson's disease	0.000419	0.000637	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000403	0.000614	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FGF20—Parkinson's disease	0.000401	0.000611	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TALDO1—Parkinson's disease	0.000398	0.000606	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—OMD—Parkinson's disease	0.000398	0.000606	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000394	0.000599	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000393	0.000598	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—EDN1—Parkinson's disease	0.00039	0.000593	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000389	0.000592	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EDN1—Parkinson's disease	0.000387	0.000589	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—IL6—Parkinson's disease	0.000387	0.000589	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RIT2—Parkinson's disease	0.000385	0.000586	CbGpPWpGaD
Danazol—AR—Gene Expression—RPL6—Parkinson's disease	0.000384	0.000584	CbGpPWpGaD
Danazol—PGR—Gene Expression—RPL14—Parkinson's disease	0.000382	0.000581	CbGpPWpGaD
Danazol—PGR—Gene Expression—RPL23A—Parkinson's disease	0.000382	0.000581	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00038	0.000578	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NDUFB11—Parkinson's disease	0.000378	0.000575	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000375	0.00057	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000371	0.000565	CbGpPWpGaD
Danazol—ESR1—Gene Expression—TAF1—Parkinson's disease	0.00037	0.000563	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NR4A2—Parkinson's disease	0.00037	0.000563	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—INS—Parkinson's disease	0.000369	0.000561	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FGF20—Parkinson's disease	0.000367	0.000559	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GRK5—Parkinson's disease	0.000365	0.000556	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GCH1—Parkinson's disease	0.00036	0.000548	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—INSR—Parkinson's disease	0.000359	0.000547	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000356	0.000542	CbGpPWpGaD
Danazol—PGR—Gene Expression—RPS8—Parkinson's disease	0.000356	0.000542	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ADORA2A—Parkinson's disease	0.000356	0.000542	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EDN1—Parkinson's disease	0.000354	0.000539	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000347	0.000528	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—CTGF—Parkinson's disease	0.000346	0.000527	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VPS35—Parkinson's disease	0.000341	0.000519	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000341	0.000519	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—FGB—Parkinson's disease	0.000339	0.000517	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000339	0.000515	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000339	0.000515	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HTR1A—Parkinson's disease	0.000338	0.000514	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—IL6—Parkinson's disease	0.000337	0.000513	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000334	0.000509	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TAC1—Parkinson's disease	0.000333	0.000506	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—INSR—Parkinson's disease	0.000328	0.0005	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GRM4—Parkinson's disease	0.000327	0.000498	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—DRD1—Parkinson's disease	0.000326	0.000496	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000325	0.000495	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GBA—Parkinson's disease	0.000321	0.000489	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—FBP1—Parkinson's disease	0.000321	0.000489	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—DBH—Parkinson's disease	0.000321	0.000489	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—DRD3—Parkinson's disease	0.000316	0.000481	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000311	0.000473	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PENK—Parkinson's disease	0.00031	0.000472	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—FGB—Parkinson's disease	0.00031	0.000472	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAG—Parkinson's disease	0.00031	0.000472	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HTR2A—Parkinson's disease	0.00031	0.000471	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—IL6—Parkinson's disease	0.000309	0.00047	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HTR1A—Parkinson's disease	0.000309	0.00047	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000307	0.000468	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TAC1—Parkinson's disease	0.000304	0.000463	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—DRD1—Parkinson's disease	0.000298	0.000454	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RPL6—Parkinson's disease	0.000296	0.00045	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000295	0.000449	CbGpPWpGaD
Danazol—AR—Gene Expression—RPL14—Parkinson's disease	0.000291	0.000443	CbGpPWpGaD
Danazol—AR—Gene Expression—RPL23A—Parkinson's disease	0.000291	0.000443	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—DRD3—Parkinson's disease	0.000289	0.00044	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000286	0.000435	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—DRD2—Parkinson's disease	0.000286	0.000435	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HTR7—Parkinson's disease	0.000286	0.000435	CbGpPWpGaD
Danazol—PGR—Gene Expression—HSPA8—Parkinson's disease	0.000285	0.000434	CbGpPWpGaD
Danazol—PGR—Gene Expression—CTGF—Parkinson's disease	0.000284	0.000432	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PDYN—Parkinson's disease	0.000284	0.000432	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GPR37—Parkinson's disease	0.000283	0.00043	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DGKQ—Parkinson's disease	0.000283	0.00043	CbGpPWpGaD
Danazol—AR—Gene Expression—RPS8—Parkinson's disease	0.000271	0.000413	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ADRBK1—Parkinson's disease	0.00027	0.00041	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GFAP—Parkinson's disease	0.000267	0.000406	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GRM5—Parkinson's disease	0.000264	0.000402	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HTR7—Parkinson's disease	0.000261	0.000398	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—DRD2—Parkinson's disease	0.000261	0.000398	CbGpPWpGaD
Danazol—PGR—Gene Expression—HSPA1A—Parkinson's disease	0.00026	0.000395	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000259	0.000394	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000257	0.000392	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000252	0.000383	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000248	0.000378	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000243	0.00037	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF2—Parkinson's disease	0.000239	0.000364	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000237	0.00036	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—DDC—Parkinson's disease	0.000236	0.000359	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGF20—Parkinson's disease	0.000231	0.000352	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF1R—Parkinson's disease	0.000231	0.000352	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000231	0.000351	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.00023	0.00035	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EDN1—Parkinson's disease	0.000229	0.000348	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000227	0.000345	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RIT2—Parkinson's disease	0.000226	0.000344	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADORA2A—Parkinson's disease	0.000224	0.000342	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RPL23A—Parkinson's disease	0.000224	0.000341	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RPL14—Parkinson's disease	0.000224	0.000341	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTA4—Parkinson's disease	0.000223	0.000339	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00022	0.000334	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF2—Parkinson's disease	0.000219	0.000333	CbGpPWpGaD
Danazol—AR—Gene Expression—HSPA8—Parkinson's disease	0.000217	0.000331	CbGpPWpGaD
Danazol—AR—Gene Expression—CTGF—Parkinson's disease	0.000216	0.000329	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRK5—Parkinson's disease	0.000214	0.000326	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF1R—Parkinson's disease	0.000212	0.000322	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NGF—Parkinson's disease	0.00021	0.00032	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EDN1—Parkinson's disease	0.000209	0.000318	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RPS8—Parkinson's disease	0.000209	0.000318	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—INSR—Parkinson's disease	0.000207	0.000315	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PLA2G6—Parkinson's disease	0.0002	0.000305	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HTR2A—Parkinson's disease	0.0002	0.000304	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MAOB—Parkinson's disease	0.000198	0.000302	CbGpPWpGaD
Danazol—AR—Gene Expression—HSPA1A—Parkinson's disease	0.000198	0.000301	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGB—Parkinson's disease	0.000196	0.000298	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HTR1A—Parkinson's disease	0.000195	0.000296	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRM4—Parkinson's disease	0.000192	0.000292	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NGF—Parkinson's disease	0.000192	0.000292	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TAC1—Parkinson's disease	0.000192	0.000292	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000191	0.00029	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.00019	0.000289	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000189	0.000288	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000189	0.000287	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000188	0.000286	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—DRD1—Parkinson's disease	0.000188	0.000286	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000187	0.000285	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000187	0.000285	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APOE—Parkinson's disease	0.000186	0.000283	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HTR2A—Parkinson's disease	0.000183	0.000278	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PENK—Parkinson's disease	0.000182	0.000277	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAG—Parkinson's disease	0.000182	0.000277	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—DRD3—Parkinson's disease	0.000182	0.000277	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—IL6—Parkinson's disease	0.000181	0.000276	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000174	0.000265	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000172	0.000262	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ADRBK1—Parkinson's disease	0.00017	0.000259	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APOE—Parkinson's disease	0.00017	0.000259	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HSPA8—Parkinson's disease	0.000167	0.000255	CbGpPWpGaD
Danazol—ESR1—Gene Expression—CTGF—Parkinson's disease	0.000167	0.000254	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDYN—Parkinson's disease	0.000167	0.000254	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—DRD2—Parkinson's disease	0.000165	0.000251	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HTR7—Parkinson's disease	0.000165	0.000251	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—INS—Parkinson's disease	0.000159	0.000242	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GFAP—Parkinson's disease	0.000157	0.000238	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRM5—Parkinson's disease	0.000155	0.000236	CbGpPWpGaD
Danazol—ESR1—Gene Expression—HSPA1A—Parkinson's disease	0.000152	0.000232	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP2D6—Parkinson's disease	0.000147	0.000224	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—INS—Parkinson's disease	0.000145	0.000221	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CTGF—Parkinson's disease	0.000145	0.00022	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF2—Parkinson's disease	0.000138	0.00021	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF20—Parkinson's disease	0.000136	0.000207	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP2E1—Parkinson's disease	0.000135	0.000205	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1R—Parkinson's disease	0.000133	0.000203	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NQO1—Parkinson's disease	0.000133	0.000203	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EDN1—Parkinson's disease	0.000132	0.000201	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000132	0.0002	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TH—Parkinson's disease	0.000131	0.0002	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYCS—Parkinson's disease	0.000126	0.000192	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000124	0.000188	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000124	0.000188	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—INSR—Parkinson's disease	0.000122	0.000185	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NGF—Parkinson's disease	0.000121	0.000184	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CASP3—Parkinson's disease	0.000118	0.00018	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL6—Parkinson's disease	0.000118	0.000179	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000116	0.000177	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000116	0.000177	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HTR2A—Parkinson's disease	0.000115	0.000176	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGB—Parkinson's disease	0.000115	0.000175	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000114	0.000174	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TAC1—Parkinson's disease	0.000113	0.000171	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—COMT—Parkinson's disease	0.000112	0.00017	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTP1—Parkinson's disease	0.000111	0.000169	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MAOA—Parkinson's disease	0.000111	0.000169	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DRD1—Parkinson's disease	0.00011	0.000168	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.00011	0.000168	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—HMOX1—Parkinson's disease	0.00011	0.000167	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK8—Parkinson's disease	0.000109	0.000165	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—Parkinson's disease	0.000108	0.000165	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—Parkinson's disease	0.000107	0.000164	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—Parkinson's disease	0.000107	0.000163	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DRD3—Parkinson's disease	0.000107	0.000163	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCB1—Parkinson's disease	0.000105	0.00016	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000105	0.00016	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—Parkinson's disease	0.000102	0.000156	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRBK1—Parkinson's disease	9.98e-05	0.000152	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK8—Parkinson's disease	9.94e-05	0.000151	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GPX1—Parkinson's disease	9.79e-05	0.000149	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DRD2—Parkinson's disease	9.67e-05	0.000147	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR7—Parkinson's disease	9.67e-05	0.000147	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FBP1—Parkinson's disease	9.37e-05	0.000143	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DBH—Parkinson's disease	9.37e-05	0.000143	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GBA—Parkinson's disease	9.37e-05	0.000143	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—INS—Parkinson's disease	9.16e-05	0.000139	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—Parkinson's disease	9.03e-05	0.000137	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—Parkinson's disease	8.41e-05	0.000128	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF2—Parkinson's disease	8.1e-05	0.000123	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1R—Parkinson's disease	7.83e-05	0.000119	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EDN1—Parkinson's disease	7.74e-05	0.000118	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—INS—Parkinson's disease	7.18e-05	0.000109	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NGF—Parkinson's disease	7.11e-05	0.000108	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—Parkinson's disease	6.94e-05	0.000106	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DDC—Parkinson's disease	6.88e-05	0.000105	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—Parkinson's disease	6.82e-05	0.000104	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR2A—Parkinson's disease	6.77e-05	0.000103	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTA4—Parkinson's disease	6.5e-05	9.89e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—Parkinson's disease	6.35e-05	9.66e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—Parkinson's disease	6.3e-05	9.58e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK8—Parkinson's disease	6.27e-05	9.54e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	5.85e-05	8.9e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MAOB—Parkinson's disease	5.79e-05	8.81e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—INS—Parkinson's disease	5.38e-05	8.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.3e-05	6.55e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CTGF—Parkinson's disease	4.22e-05	6.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—Parkinson's disease	4e-05	6.09e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—Parkinson's disease	4e-05	6.09e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.94e-05	5.99e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.89e-05	5.92e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TH—Parkinson's disease	3.84e-05	5.84e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.68e-05	5.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK8—Parkinson's disease	3.68e-05	5.6e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—COMT—Parkinson's disease	3.26e-05	4.96e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.25e-05	4.94e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.24e-05	4.93e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.2e-05	4.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.07e-05	4.68e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.98e-05	4.54e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.86e-05	4.35e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.64e-05	4.01e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—Parkinson's disease	2.45e-05	3.73e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—Parkinson's disease	2.35e-05	3.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—INS—Parkinson's disease	2.1e-05	3.19e-05	CbGpPWpGaD
